The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug

1 month ago 9

Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders.